First drug to delay onset of type 1 diabetes made available on NHS
The NHS in England and Wales has introduced Teplizumab, the first drug capable of delaying the onset of type 1 diabetes. The immunotherapy treatment can provide patients with three additional years before requiring daily insulin management.
Why it matters
This represents a major medical breakthrough in diabetes management, potentially improving the quality of life for hundreds of young patients annually.
Share Save Add as preferred on Google Jim Reed Health reporter Family photo Theo Sebastian-Jenkin was diagnosed with type 1 diabetes as a young boy after displaying extreme fatigue, weight loss and other symptoms The first drug that can delay the onset of type 1 diabetes is being made available on the NHS in England and Wales.
The article provides a factual overview of a medical development and its impact on patients, citing both charities and health bodies.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in